5 min read
4 min read
Georgia Tech researcher Nick Housley is developing a drug‑delivery system designed to send cancer treatments directly to tumors while minimizing damage to healthy tissue. His team’s approach uses self‑assembling nanohydrogels (SANGs) that circulate through the body, remain inactive in healthy environments, and release their drug payload only when they encounter the unique chemical conditions created by tumors.
3 min read
The project aims to move lymphatic disease out of the medical margins and toward patients who have had few meaningful treatment options.
8 min read
Gary Spinner’s unexpected path into higher education and microfabrication began after he shifted from working as a teenage cook to studying electronics, eventually launching a semiconductor career with IBM and Intel before joining Georgia Tech in 1994.
3 min read
4 min read
3 min read
5 min read
3 min read
3 min read




